Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
<h4>Introduction</h4>The traditional staging system is inadequate to identify those patients with stage II colorectal cancer (CRC) at high risk of recurrence or with stage III CRC at low risk. A number of gene expression signatures to predict CRC prognosis have been proposed, but none is...
Guardado en:
Autores principales: | Rebeca Sanz-Pamplona, Antoni Berenguer, David Cordero, Samantha Riccadonna, Xavier Solé, Marta Crous-Bou, Elisabet Guinó, Xavier Sanjuan, Sebastiano Biondo, Antonio Soriano, Giuseppe Jurman, Gabriel Capella, Cesare Furlanello, Victor Moreno |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07e22085fbab488d96e4d6101fd40804 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Discovery and validation of new potential biomarkers for early detection of colon cancer.
por: Xavier Solé, et al.
Publicado: (2014) -
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
por: Ombretta Melaiu, et al.
Publicado: (2020) -
Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.
por: Nuria Seguí, et al.
Publicado: (2014) -
Effect of size and heterogeneity of samples on biomarker discovery: synthetic and real data assessment.
por: Barbara Di Camillo, et al.
Publicado: (2012) -
Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
por: Gemma Ibáñez-Sanz, et al.
Publicado: (2021)